Literature DB >> 31163199

The genus Tripterygium: A phytochemistry and pharmacological review.

Huawei Lv1, Liangping Jiang1, Mengdi Zhu2, Yuxia Li1, Meng Luo1, Peiheng Jiang3, Shengqiang Tong1, Hongjian Zhang4, Jizhong Yan5.   

Abstract

The genus Tripterygium belongs to the family Celastraceae, and contains three species, i.e. Tripterygium wilfordii Hook. F, Tripterygium hypoglaucum (Levl.) Hutch. and Tripterygium regelii Sprague et Takeda. All three species are reported to have excellent medicinal properties that help to cure rheumatoid arthritis, nephrotic syndrome, systemic lupus erythematosus and widely used as a folk medicine in China. Phytochemical studies have led to discovering more than 500 secondary metabolites in this genus, including five main types: sesquiterpenoids, diterpenes, triterpenoids, flavonoids, lignans. This work provides structurally grouping statistic of 198 secondary metabolites of Tripterygium species published from 2008 to the present, as well as pharmacological knowledges in the past five years. The information will be helpful for developing the new discoveries of medicinal value related to the genus Tripterygium.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Celastraceae; Metabolism; Pharmacology; Phytochemistry; Toxicity; Tripterygium

Mesh:

Substances:

Year:  2019        PMID: 31163199     DOI: 10.1016/j.fitote.2019.104190

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  8 in total

1.  Synchronous Investigation of the Mechanism and Substance Basis of Tripterygium Glycosides Tablets on Anti-rheumatoid Arthritis and Hepatotoxicity.

Authors:  Qi Qian; Yanhua Gao; Ge Xun; Xu Wang; Jiachen Ge; Huaxing Zhang; Feifei Mou; Suwen Su; Qiao Wang
Journal:  Appl Biochem Biotechnol       Date:  2022-06-28       Impact factor: 3.094

2.  Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.

Authors:  Dan Zhang; Yizhu Dong; Jintao Lv; Bing Zhang; Xiaomeng Zhang; Zhijian Lin
Journal:  BMC Complement Med Ther       Date:  2021-01-15

Review 3.  Emerging Natural-Product-Based Treatments for the Management of Osteoarthritis.

Authors:  Maria-Luisa Pérez-Lozano; Annabelle Cesaro; Marija Mazor; Eric Esteve; Sabine Berteina-Raboin; Thomas M Best; Eric Lespessailles; Hechmi Toumi
Journal:  Antioxidants (Basel)       Date:  2021-02-09

4.  Qingluo Tongbi Formula Alleviates Hepatotoxicity Induced by Tripterygium wilfordii Hook. F. by Regulating Excessive Mitophagy Through the PERK-ATF4 Pathway.

Authors:  Linluo Zhang; Jie Zhou; Zhe Feng; Baoping Jiang; Changqing Li; Lingling Zhou; Xueping Zhou
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

5.  Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9/p38 MAPK pathway.

Authors:  Lu Zhao; Zhixin Lan; Liang Peng; Lili Wan; Di Liu; Xia Tan; Chengyuan Tang; Guochun Chen; Hong Liu
Journal:  Cell Prolif       Date:  2022-06-22       Impact factor: 8.755

6.  Comprehensive Evaluation of the Quality of Tripterygium Glycosides Tablets Based on Multi-Component Quantification Combined with an In Vitro Biological Assay.

Authors:  Yadan Wang; Zhong Dai; Jiangong Yan; Xianfu Wu; Shuangcheng Ma
Journal:  Molecules       Date:  2022-08-10       Impact factor: 4.927

Review 7.  Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives.

Authors:  Jie Gao; Yifeng Zhang; Xihong Liu; Xiayi Wu; Luqi Huang; Wei Gao
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

Review 8.  Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study.

Authors:  Lihong Yang; Xueyin Chen; Chuang Li; Peng Xu; Wei Mao; Xing Liang; Qi Zuo; Weizhong Ma; Xinfeng Guo; Kun Bao
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.